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CA score, where 30% had coronary stenting, 20% had
bypass surgery , 35% had mild disease, and 15% had
non obstructive lesions.
Conclusion: Negative calcium score excludes CAD
in 90% of patients as confirmed by normal CTA. Coro-
nary CTA is an important tool to detect early coronary
atherosclerosis even in absence of coronary calcification.
http://dx.doi:10.1016/j.jsha.2012.06.258
Effect of intracoronary (IC) transplantation of
autologous bone marrow-derived mesenchymal
stem cells (BMSC) in patients with advanced left
ventricular systolic dysfunction
Tamer El Khayat, Wael Aboul Kheir, Gamal Aboul
Nasr
Background: In the absence of cardiac transplanta-
tion programs and high cost of CRT-ICD in our commu-
nity, large numbers of no-option HF patients (pts) for
revascularization are still markedly symptomatic. IC-
BMSC appears as promising option.
Methods: 33 (27 males) with chronic HF, LVEF 6 35
and mean age 46 y divided into 2 groups, 17 BMSC pts
and 16 pts control. Both were maintained on maximum
tolerated medications (follow-up 258 + 47 days). NYHA
function class (NYHAFC), six minutes walking test
(6MWT), LVESD, LVEDD, 2D-LVEF, systolic (S) and ear-
lydiastolic (E) mitral annulus velocities by TDI evaluated.
BMSC were obtained and selectively IC injected.
Results: Both groups showed improvement in
NYHAFC from 3 to 2, P < 0.001 in BMSC, P < 0.04 for con-
trol. 6MWT marginally improved in BMSC from 348 ± 91
to 406 ± 87 meters (m) P < 0.06 while no improvement was
noticed in control (361 ± 47 to 336 ± 110M, PNS). LVESD
Figure 1.
Figure 2.
A
BSTR
A
C
TS
298 23RD ANNUAL INTERNATIONAL CONFERENCE J Saudi Heart Assoc
2012;24:271–304
significantly decreased from 6.1 ± 0.8 to 5.7 ± 0.7 cm in
BMSC, P < 0.028 while no changes occurred in the control
group from 6.7 ± 1.0 to 6.6 ± 1.1 cm, PNS. No changes
occurred in LVEDD from 7.1 ± 0.9 to 6.9 ± 0.7 cm in BMSC
and from7.6 ± 1.1 to 7.56 ± 1.1 cm in control, PNS for both.
No significant changes in LVEF occurred in control
(26 ± 6 to 27 ± 7% PNS), while a trend for improvement
occurred BMSC from 29 ± 6 to 33 ± 10%, P < 0.059. Mitral
S wave showed trend for increase in MBSC (from 4.8 ± 1.5
to 5.3 ± 1.2 cm/s P < 0.058 while no changes occurred in
control (5.2 ± 1.7 to 5.2 ± 1.5 cm/s). Mitral E wave showed
non-significant increase from 5.7 ± 2.5 to 6.3 ± 2.6 cm/s in
BMSC, non-significant decrease was noticed in control
from 7.6 ± 2.4 to 7.1 ± 2.7 cm/s, PNS for both. There was
no procedure related morbidity or mortality in the BMSC
group.
Conclusion: On top of standard and maximum toler-
ated medical treatment for chronic systolic HF, the addi-
tion of intracoronary autologous BMSC is feasible, safe
and associated with subjective and objective functional
improvement with trend towards improvement in
parameters of LV performance.
http://dx.doi:10.1016/j.jsha.2012.06.259
Prognostic significance of high sensitivity C-reac-
tive protein in patients with angina pectoris
underwent percutaneous coronary intervention
Yehia T. Kishk, Amr A. Youssef, Tayeb A. Bafadhl
Background: C-reactive protein is an easily measur-
able acute phase reactant synthesized by hepatocytes in
response to pro-inflammatory cytokines. Elevated CRP
has been identified as a strong predictor of prognosis in
healthy individuals, in patients with stable angina, in
unstable angina and in patients after acute myocardial
infarction. The prognostic significance of high sensitivity
CRP level in percutaneous coronary intervention is
unclear.
Methods: We prospectively studied 41 patients with
chronic stable angina (28 patients) and unstable angina
(13 patients) who underwent elective coronary stenting.
All patients had normal troponin level before the proce-
dure. Blood samples for hs-CRP were obtained before the
procedure, 24 h after the procedure. Patients followed up
at 1 month and after 2 years.
Results: Mean hs_CRP before the procedure in all
patients underwent PCI was 2.38 ± 2.21 lg/ml. The mean
hs_CRP 24 h post procedure was 7.43 ± 10.6 lg/ml .There
was significant difference between pre procedural hs-
CRP and 24 h post procedural (P = 0.007). At follow up
period (1 month), no major adverse cardiac events
(MACE) have occurred. However, 24 patients complain
of chest pain. There was no significant correlation
between either pre-procedural, or 24 h post procedure
hs-CRP and chest pain (r = 0.13, 0.2, respectively). At fol-
low up period (2 years), 7 cases missed; MACE has
occurred in 13 patients.
Conclusion: Mechanical disruption of atherosclerotic
plaque during elective coronary stent implantation
causes a systemic inflammatory response. Measuring of
hs-CRP either pre-procedural or post procedural in low
risk patients is not useful for predicting of either early
or late cardiovascular events.
1. Introduction:
C - reactive protein (CRP) is an acute phase reac-
tant that responds as a sensitive, though non spe-
cific marker of systemic inflammation. This
protein is synthesized by the liver in response to
stimuli from circulating inflammatory cytokines.
CRP has traditionally been used as a systemic mar-
ker of infection and tissue injury [1].
C-reactive protein has been identified as a
strong predictor of prognosis in healthy individuals
[2,3], in patients with stable angina [4–7] and unsta-
ble angina [8–13], and in patients after an acute
myocardial infarction [14,15].
Percutaneous coronary intervention (PCI) with
stent implantation is a mainstay in the manage-
ment of severe coronary artery atherosclerotic dis-
ease. Indeed, PCI currently outperforms coronary
artery bypass grafting, and the use of interven-
tional procedures is projected to increase even
more with the adoption of new-generation drug-
eluting stents [16].
Several studies have examined the prognostic
role of CRP levels after elective or emergent PCI
with a positive prognostic impact. On the other
hand, other interventional studies failed to show a
significant correlation between CRP levels and
recurrent events or re-stenosis after elective or
emergent PCI.
Increased C-reactive protein may become an
important factor in pre-procedural risk stratifica-
tion. As an independent marker for the rapid pro-
gression of atherosclerosis or the presence of an
increased risk of subsequent adverse clinical out-
come, increased C-reactive protein may identify
high-risk patients as candidates for high dose lipid
lowering therapy and treatment with ACE inhibi-
tion [17].
The aim of this study is to assess the hs-CRP
value and its prognostic significance in long term
follow up after PCI.
2. Methods:
From March 2008 to March 2009, 41 patients, 28
of them with the diagnosis of chronic stable angina
and 13 with the diagnosis of unstable angina were
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